Position in ROIV
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$3,680
+$1,825 QoQ
Shares Held
104
+55.2% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#442
of 494 holders
Holding Since
Sep 2023
7 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ROIV Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026HARBOUR INVESTMENTS, INC. holds $3,692,478 across 135 Biotechnology names. ROIV ranks #60 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VKTX |
Viking Therapeutics, Inc.
|
16,451 | $641,753 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
636 | $396,571 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
734 | $364,599 | |
| 4 | JAZZ |
Jazz Pharmaceuticals plc
|
1,365 | $328,924 | |
| 5 | OMER |
Omeros Corp
|
23,139 | $220,051 | |
| 6 | CRSP |
CRISPR Therapeutics AG
|
3,533 | $192,689 | |
| 7 | STOK |
Stoke Therapeutics, Inc.
|
4,413 | $144,393 | |
| 8 | NTLA |
Intellia Therapeutics, Inc.
|
7,534 | $127,475 |
All Filings in ROIV
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,680 | 104 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $1,855 | 67 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $7,942 | 366 | Shares | Sole | 2026-02-09 | |
| 2024-06-30 | $10,570 | 1,000 | Shares | Sole | 2024-07-26 | |
| 2024-03-31 | $10,540 | 1,000 | Shares | Sole | 2024-07-22 | |
| 2023-12-31 | $11,230 | 1,000 | Shares | Sole | 2024-02-16 | |
| 2023-09-30 | $11,680 | 1,000 | Shares | Sole | 2023-11-15 | |
| No filing history on record for this holder in this stock. | ||||||